An observational study in New Strategies, GINA 2006 and Patient Opinion, sponsored by AstraZeneca. Completed at 31 sites in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-04-30.
Sponsored by AstraZeneca · Observational
Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.
AstraZeneca is the lead sponsor of 3,429 studies on the registry; 270 are open to participants now.
Of its 357 completed or terminated interventional studies of FDA-regulated products, 173 (48%) have results posted.
Counted across the registry records on this site, refreshed daily.
Primary care
Exclusion Criteria:
Percentage (%) of Asthma treatment satisfaction and control grading
Time frame: single visit / once
Rate of treatment compliance
Time frame: single visit / once
Patients quality of life under treatment
Time frame: single visit / once
This study is completed, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AstraZeneca